Literature DB >> 23252903

The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice.

Ted M Burns1.   

Abstract

The myasthenia gravis composite (MGC) was constructed by selecting the best performing items from three commonly used, MG-specific scales. The response categories of the items were subsequently weighted for importance. The MGC, which takes less than five minutes to complete, is made up of three ocular, three bulbar, one respiratory, one neck, and two limb items. After its construction, the MGC was validated in an 11-center scale validity study. During the validation study, which included test-retest analysis, it was determined that a 3-point improvement in MGC score reliably indicates clinical improvement. A 3-point improvement in MGC also appears to be meaningful to the patient. Rasch analysis of the MGC confirmed that all 10 items belong and can be summed to provide a total score, and that the weights given to the response categories of the items are appropriate.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2012        PMID: 23252903     DOI: 10.1111/j.1749-6632.2012.06812.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

Review 1.  Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status.

Authors:  Grayson Beecher; Brendan Nicholas Putko; Amanda Nicole Wagner; Zaeem Azfer Siddiqi
Journal:  Drugs       Date:  2019-03       Impact factor: 9.546

Review 2.  Eculizumab: A Review in Generalized Myasthenia Gravis.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

3.  Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study.

Authors:  Ying Tan; Jiayu Shi; Yangyu Huang; Ke Li; Jingwen Yan; Li Zhu; Yuzhou Guan; Liying Cui
Journal:  Front Neurol       Date:  2022-06-13       Impact factor: 4.086

4.  Respiratory Muscle Training Improves Functional Outcomes and Reduces Fatigue in Patients with Myasthenia Gravis: A Single-Center Hospital-Based Prospective Study.

Authors:  Che-Wei Hsu; Hui-Chen Lin; Wan-Chen Tsai; Yun-Ru Lai; Chih-Cheng Huang; Yu-Jih Su; Ben-Chung Cheng; Mao-Chang Su; Wei-Che Lin; Chia-Ling Chang; Wen-Neng Chang; Meng-Chih Lin; Cheng-Hsien Lu; Nai-Wen Tsai
Journal:  Biomed Res Int       Date:  2020-03-19       Impact factor: 3.411

5.  Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis.

Authors:  Laura Díez-Porras; Christian Homedes; Maria Antonia Alberti; Valentina Vélez-Santamaría; Carlos Casasnovas
Journal:  Sci Rep       Date:  2020-08-11       Impact factor: 4.379

6.  Oral function in patients with myasthenia gravis.

Authors:  Agnete Overgaard Donskov; Akiko Shimada; Lotte Vinge; Peter Svensson; Henning Andersen
Journal:  PeerJ       Date:  2021-06-29       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.